Armbruster Capital Management, Inc. Johnson & Johnson Transaction History

Armbruster Capital Management, Inc.

$500 Million
Q3 2024

A detailed history of Armbruster Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Armbruster Capital Management, Inc. holds 1,260 shares of JNJ stock, worth $195,804. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,260

Previous 1,830 31.15%

Holding current value

$195,804

Previous $267,000 23.6%

% of portfolio

0.04%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$145.48 - $167.38 $82,923 - $95,406	-570 Reduced 31.15%	1,260 $204,000
Q2 2024 Jul 29, 2024	SELL	$144.38 - $157.78 $10,828 - $11,833	-75 Reduced 3.94%	1,830 $267,000
Q4 2023 Feb 01, 2024	SELL	$145.6 - $158.88 $145 - $158	-1 Reduced 0.05%	1,905 $298,000
Q3 2023 Oct 17, 2023	SELL	$155.75 - $174.48 $101,237 - $113,412	-650 Reduced 25.43%	1,906 $296,000
Q2 2023 Aug 03, 2023	BUY	$154.35 - $166.11 $16,669 - $17,939	108 Added 4.41%	2,556 $423,000
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $83,077 - $99,143	-550 Reduced 18.35%	2,448 $379,000
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $8,009 - $8,989	-50 Reduced 1.64%	2,998 $529,000
Q3 2022 Oct 19, 2022	SELL	$161.33 - $179.52 $76,631 - $85,272	-475 Reduced 13.48%	3,048 $498,000
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $1,681 - $1,860	-10 Reduced 0.28%	3,523 $625,000
Q1 2022 May 05, 2022	BUY	$158.14 - $179.59 $19,767 - $22,448	125 Added 3.67%	3,533 $626,000
Q4 2021 Feb 15, 2022	BUY	$155.93 - $173.01 $22,297 - $24,740	143 Added 4.38%	3,408 $583,000
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $2,742 - $3,147	-20 Reduced 0.61%	3,265 $514,000
Q3 2020 Oct 30, 2020	BUY	$140.38 - $153.83 $421 - $461	3 Added 0.09%	3,285 $489,000
Q2 2020 Aug 10, 2020	BUY	$128.81 - $155.51 $2,189 - $2,643	17 Added 0.52%	3,282 $462,000
Q1 2020 May 08, 2020	SELL	$111.14 - $153.99 $36,120 - $50,046	-325 Reduced 9.05%	3,265 $428,000
Q3 2019 Nov 08, 2019	SELL	$126.95 - $142.14 $16,884 - $18,904	-133 Reduced 3.57%	3,590 $464,000
Q2 2019 Jul 18, 2019	SELL	$131.15 - $144.24 $25,049 - $27,549	-191 Reduced 4.88%	3,723 $519,000
Q1 2019 Apr 16, 2019	SELL	$125.72 - $139.79 $11,943 - $13,280	-95 Reduced 2.37%	3,914 $547,000
Q4 2018 Jan 28, 2019	SELL	$122.84 - $147.84 $27,884 - $33,559	-227 Reduced 5.36%	4,009 $517,000
Q3 2018 Oct 22, 2018	BUY	$121.58 - $142.88 $66,990 - $78,726	551 Added 14.95%	4,236 $585,000
Q2 2018 Jul 30, 2018	SELL	$119.4 - $131.76 $7,641 - $8,432	-64 Reduced 1.71%	3,685 $447,000
Q1 2018 Apr 18, 2018	SELL	$125.1 - $148.14 $72,307 - $85,624	-578 Reduced 13.36%	3,749 $480,000
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $2,624 - $2,872	-20 Reduced 0.46%	4,327 $605,000
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $562,806 - $588,496	4,347	4,347 $565,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armbruster Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Armbruster Capital Management, Inc. with notifications on news.

Account

Armbruster Capital Management, Inc. Johnson & Johnson Transaction History